D-0609-2026 Class II Ongoing
FDA drug recall D-0609-2026 was initiated by The Harvard Drug Group LLC on June 16, 2026 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 790 Cartons..
Recall Details
- Product Type
- Drugs
- Report Date
- July 1, 2026
- Initiation Date
- June 16, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 790 Cartons.
Product Description
Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.
Reason for Recall
Subpotent Drug
Distribution Pattern
U.S. Nationwide.
Code Information
Lots: N02327, expires: 09/2026; N02740, expires: 12/2026; N03069, expires: 08/2027.